Published on 2/16/2006 in the Prospect News Biotech Daily.
New Issue: Adolor raises $125 million in follow-on at $25, discounted from $25.19 close
By Ronda Fears
Memphis, Feb. 16 - Adolor Corp. priced a follow-on offering of 5 million shares of common stock off the shelf at $25.00 per share, discounted from Wednesday's closing level of $25.19, via bookrunner Lehman Brothers Inc.
Exton, Pa.-based Adolor, which concentrates of pain medications, plans to use proceeds for general corporate purposes, which may include increasing its working capital, acquisitions, in-licensing of products or technologies and capital expenditures.
Issuer: | Adolor Corp.
|
Issue: | Follow-on stock offering
|
Gross proceeds: | $125 million
|
Net proceeds: | $117 million
|
Shares: | 5 million shares
|
Greenshoe: | 825,000 shares
|
Price: | $25.00 per share
|
Bookrunner: | Lehman Brothers Inc.
|
Co-managers: | Pacific Growth Equities, LLC, Banc of America Securities, LLC and J.P. Morgan Securities Inc.
|
Pricing date: | Feb. 15
|
Settlement date: | Feb. 22
|
Stock symbol: | Nasdaq: ADLR
|
Stock price: | $25.19 at close Feb. 15
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.